Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 14, 2020; 26(6): 645-656
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.645
Published online Feb 14, 2020. doi: 10.3748/wjg.v26.i6.645
Characteristic | All patients (n = 1281) | Without BI (n = 921) | With BI (n = 360) | P value |
Median age (IQR) -yr | 51 (42-57) | 52 (43-57) | 50 (42-57) | 0.16 |
Male sex (%) | 1012 (79) | 726 (78.8) | 286 (79.4) | 0.88 |
Concomitant etiology of cirrhosis (%) | ||||
Alcohol | 142 (11.1) | 102 (11.1) | 40 (11.1) | 1.00 |
Others | 48 (3.7) | 36 (3.9) | 12 (3.3) | 0.74 |
HBeAg positive HBV (%)1 | 421/1122 (37.5) | 298/794 (37.5) | 123/328 (37.5) | 1.00 |
Experience of anti-HBV treatment (%)1 | 284/1176 (24.2) | 183/851 (21.5) | 101/325 (31.1) | < 0.001 |
Decompensations (%)2 | ||||
Ascites | 1099 (85.8) | 773 (83.9) | 326 (90.6) | < 0.01 |
Jaundice | 534 (41.7) | 297 (32.2) | 237 (65.8) | < 0.001 |
Gastrointestinal variceal bleeding | 336 (26.2) | 280 (30.4) | 56 (15.6) | < 0.001 |
Hepatic encephalopathy | 190 (14.8) | 82 (8.9) | 108 (30) | < 0.001 |
ACLF at admission (%) | 284 (22.2) | 130 (14.1) | 154 (42.8) | < 0.001 |
Median value for laboratory tests (IQR) | ||||
Log10 HBV DNA (copies/mL)3 | 4.7 (3.1-6.1) | 4.8 (3-6.2) | 4.6 (3.1-5.7) | 0.33 |
Hemoglobin (g/L) | 103 (83-121) | 102 (82-119) | 107 (87-127) | < 0.001 |
White cell count: × 109 cells/L | 4.7 (2.9-7.5) | 4.2 (2.7-6.1) | 6.9 (4.3-10.9) | < 0.001 |
Platelet count: × 109 cells/L | 63 (40-102) | 60 (40-96) | 70 (42-117.5) | < 0.01 |
International normalized ratio | 1.6 (1.3-2) | 1.4 (1.3-1.9) | 1.8 (1.5-2.6) | < 0.001 |
Serum sodium (mmol/L) | 136 (131.2-139) | 136 (132.3-139.3) | 134 (129-137) | < 0.001 |
Serum creatinine (mg/dL) | 0.8 (0.7-1) | 0.8 (0.7-1) | 0.8 (0.6-1.1) | 0.20 |
Aspartate aminotransferase (IU/L) | 67 (42-124) | 60 (40-107) | 97 (56.5-192) | < 0.001 |
Alanine aminotransferase (IU/L) | 47 (30-97) | 42 (29-80) | 67 (37-185.8) | < 0.001 |
Total bilirubin (mg/dL) | 3.4 (1.5-15.5) | 2.6 (1.4-8) | 10.9 (3-27.4) | < 0.001 |
Serum albumin (g/dL) | 2.8 (2.5-3.2) | 2.9 (2.5-3.3) | 2.8 (2.4-3.1) | < 0.001 |
Median value for severity scores (IQR) | ||||
Child-Pugh | 11 (9-12) | 10 (8-12) | 12 (10-13) | < 0.001 |
MELD | 16.8 (11.8-25.5) | 14.8 (11.1-22.3) | 24.4 (17.1-30.2) | < 0.001 |
- Citation: Cao ZJ, Liu YH, Zhu CW, Yin S, Wang WJ, Tang WL, Zhao GD, Xu YM, Chen L, Zhou TH, Cai MH, Wang H, Cai W, Bao SS, Li H, Xie Q. Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study. World J Gastroenterol 2020; 26(6): 645-656
- URL: https://www.wjgnet.com/1007-9327/full/v26/i6/645.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i6.645